Galmed Pharmaceuticals Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.66

+0.07 (+11.58%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +2,498.3% upside

Low Target $9.83

Average Target $17.25

High Target $23.67

Current Price $0.66

Current
$0.66

Target
$17.25

$9.83 $17.25 avg $23.67

Scenario Analysis

Bear Case

$9.83

1,380.6%

Low target

Base Case

$17.25

+2,498.3%

Avg target

Bull Case

$23.67

+3,465.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$16.48

-96.0% from high

52-Week Low

$11.93

+-94.4% from low

Target vs 52W High

$17.25

+4.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%